Profile | GDS5420 / 235475_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 46.63 | 30 |
GSM1296119 | B_lesional_pre-dose | 101.14 | 40 |
GSM1296076 | C_lesional_pre-dose | 164.86 | 51 |
GSM1296092 | D_lesional_pre-dose | 133.65 | 48 |
GSM1296103 | E_lesional_pre-dose | 69.95 | 36 |
GSM1296078 | F_lesional_pre-dose | 130.94 | 47 |
GSM1296107 | G_lesional_pre-dose | 132.28 | 44 |
GSM1296109 | H_lesional_pre-dose | 87.87 | 37 |
GSM1296080 | I_lesional_pre-dose | 37.36 | 28 |
GSM1296090 | J_lesional_pre-dose | 146.18 | 49 |
GSM1296074 | K_lesional_pre-dose | 97.47 | 44 |
GSM1296111 | L_lesional_pre-dose | 123.53 | 43 |
GSM1296099 | M_lesional_pre-dose | 72.57 | 36 |
GSM1296086 | O_lesional_pre-dose | 77.96 | 39 |
GSM1296117 | P_lesional_pre-dose | 112.34 | 41 |
GSM1296113 | Q_lesional_pre-dose | 145.44 | 44 |
GSM1296096 | R_lesional_pre-dose | 52.91 | 32 |
GSM1296105 | S_lesional_pre-dose | 80.04 | 37 |
GSM1296098 | T_lesional_pre-dose | 57.14 | 31 |
GSM1296101 | U_lesional_pre-dose | 41.08 | 28 |
GSM1296121 | V_lesional_pre-dose | 134.06 | 45 |
GSM1296088 | W_lesional_pre-dose | 122.6 | 45 |
GSM1296082 | X_lesional_pre-dose | 112.34 | 45 |
GSM1296115 | Y_lesional_pre-dose | 104.42 | 41 |
GSM1296084 | Z_lesional_pre-dose | 125.75 | 45 |
GSM1296072 | B_lesional_day8 | 178.27 | 49 |
GSM1296069 | L_lesional_day8 | 152.6 | 46 |
GSM1296071 | P_lesional_day8 | 127.19 | 42 |
GSM1296070 | Y_lesional_day8 | 115.32 | 41 |
GSM1296073 | V_lesional_day8 | 106.92 | 42 |
GSM1296034 | A_lesional_day15 | 95.19 | 40 |
GSM1296041 | G_lesional_day15 | 117.4 | 43 |
GSM1296035 | R_lesional_day15 | 83.19 | 40 |
GSM1296038 | U_lesional_day15 | 113.01 | 43 |
GSM1296047 | B_lesional_day15 | 224.21 | 53 |
GSM1296039 | E_lesional_day15 | 134.36 | 46 |
GSM1296042 | H_lesional_day15 | 172.36 | 48 |
GSM1296043 | L_lesional_day15 | 135.29 | 44 |
GSM1296037 | M_lesional_day15 | 37.75 | 25 |
GSM1296046 | P_lesional_day15 | 180.82 | 49 |
GSM1296044 | Q_lesional_day15 | 185.52 | 49 |
GSM1296045 | Y_lesional_day15 | 129.5 | 43 |
GSM1296025 | C_lesional_day15 | 127.41 | 46 |
GSM1296033 | D_lesional_day15 | 103.56 | 42 |
GSM1296027 | I_lesional_day15 | 139.33 | 49 |
GSM1296032 | J_lesional_day15 | 79.73 | 38 |
GSM1296024 | K_lesional_day15 | 110.69 | 44 |
GSM1296031 | W_lesional_day15 | 55.5 | 32 |
GSM1296028 | X_lesional_day15 | 120.75 | 45 |
GSM1296029 | Z_lesional_day15 | 109.98 | 43 |
GSM1296026 | F_lesional_day15 | 102.15 | 42 |
GSM1296030 | O_lesional_day15 | 111.84 | 46 |
GSM1296040 | S_lesional_day15 | 67.04 | 35 |
GSM1296036 | T_lesional_day15 | 106.81 | 41 |
GSM1296048 | V_lesional_day15 | 109.76 | 42 |
GSM1296059 | A_lesional_day43 | 24.79 | 22 |
GSM1296066 | G_lesional_day43 | 150.93 | 46 |
GSM1296060 | R_lesional_day43 | 94.2 | 41 |
GSM1296063 | U_lesional_day43 | 113.21 | 43 |
GSM1296064 | E_lesional_day43 | 90.62 | 40 |
GSM1296067 | H_lesional_day43 | 92.13 | 38 |
GSM1296062 | M_lesional_day43 | 49.58 | 31 |
GSM1296068 | Q_lesional_day43 | 185.73 | 49 |
GSM1296050 | C_lesional_day43 | 127.48 | 45 |
GSM1296057 | D_lesional_day43 | 121.92 | 45 |
GSM1296052 | I_lesional_day43 | 84.71 | 41 |
GSM1296054 | J_lesional_day43 | 171.36 | 49 |
GSM1296049 | K_lesional_day43 | 97.34 | 41 |
GSM1296055 | W_lesional_day43 | 77.05 | 36 |
GSM1296053 | X_lesional_day43 | 106.77 | 43 |
GSM1296058 | Z_lesional_day43 | 77.73 | 39 |
GSM1296051 | F_lesional_day43 | 94.34 | 41 |
GSM1296056 | O_lesional_day43 | 66.91 | 37 |
GSM1296065 | S_lesional_day43 | 130.51 | 45 |
GSM1296061 | T_lesional_day43 | 60.83 | 33 |
GSM1296095 | A_non-lesional_pre-dose | 133.15 | 47 |
GSM1296120 | B_non-lesional_pre-dose | 191.04 | 50 |
GSM1296077 | C_non-lesional_pre-dose | 126.07 | 46 |
GSM1296093 | D_non-lesional_pre-dose | 194.65 | 51 |
GSM1296104 | E_non-lesional_pre-dose | 186.27 | 51 |
GSM1296079 | F_non-lesional_pre-dose | 72.13 | 37 |
GSM1296108 | G_non-lesional_pre-dose | 159.72 | 48 |
GSM1296110 | H_non-lesional_pre-dose | 138.36 | 44 |
GSM1296081 | I_non-lesional_pre-dose | 78.03 | 39 |
GSM1296091 | J_non-lesional_pre-dose | 152.22 | 49 |
GSM1296075 | K_non-lesional_pre-dose | 148.75 | 49 |
GSM1296112 | L_non-lesional_pre-dose | 137.28 | 43 |
GSM1296100 | M_non-lesional_pre-dose | 104.64 | 41 |
GSM1296087 | O_non-lesional_pre-dose | 157.65 | 51 |
GSM1296118 | P_non-lesional_pre-dose | 201.58 | 51 |
GSM1296114 | Q_non-lesional_pre-dose | 194.06 | 50 |
GSM1296097 | R_non-lesional_pre-dose | 113.69 | 43 |
GSM1296106 | S_non-lesional_pre-dose | 112.81 | 42 |
GSM1296102 | U_non-lesional_pre-dose | 113.24 | 42 |
GSM1296122 | V_non-lesional_pre-dose | 124.32 | 43 |
GSM1296089 | W_non-lesional_pre-dose | 123.19 | 43 |
GSM1296083 | X_non-lesional_pre-dose | 94.08 | 41 |
GSM1296116 | Y_non-lesional_pre-dose | 168.26 | 47 |
GSM1296085 | Z_non-lesional_pre-dose | 194.68 | 52 |